Treatment of Juvenile Xanthogranuloma with Ocular Involvement

Ocular juvenile xanthogranuloma (JXG) is a specific presentation that requires a targeted therapeutic approach directed at the affected eye and surrounding structures.

Clinical Scenario

Ocular JXG is nearly always unilateral and primarily affects the iris, although involvement of the orbit, optic nerve, choroid, and conjunctiva is also recognised. This ocular distribution defines the specific clinical context for this protocol.

Treatment Approach — Partial Overview

Treatment centres on corticosteroid therapy applied directly to the affected eye. The complete protocol details the full range of options and the conditions under which each is indicated.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.adengl.2020.10.007

Ocular JXG is nearly always unilateral and generally affects the iris, although the orbit, optic nerve, choroid, and conjunctiva may also be affected.

Topical and intralesional corticoids are usually used to treat ocular JXG, while systemic corticosteroids or surgery may be needed to treat rapidly progressive lesions or complications, such as glaucoma or hyphema; there have also been isolated reports of good response to radiation therapy and chemotherapy.

View source ↗